New registry study aims to unlock secrets of diabetic foot ulcers
NCT ID NCT07188337
First seen Jun 26, 2026 · Last updated Jun 26, 2026
Summary
This study is collecting information from 200 patients with diabetic foot ulcers admitted to 5 Azar Hospital in 2024. Researchers will analyze blood tests and other data to see how they relate to ulcer severity. The goal is to find patterns that could help doctors prevent and manage these serious wounds more effectively.
What this could mean
Our plain-language read of the trial. This is informational only, not medical advice or a prediction.
- What this could lead to
- If successful, this study could help doctors better predict which diabetic foot ulcers will become severe, leading to earlier and more effective treatment.
- What could go wrong
- This is an observational registry study, not a treatment trial. It will not test any new drug or therapy, so it cannot directly improve patient outcomes.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Study facts
What this study's own registry entry says, in plain language.
- Participants
-
About 200 people
The number the study aims to enrol. It can still change while the study runs.
- Started
-
Jul 2025
- Expected to finish
-
Nov 2025
An estimate. End dates often move.
- Lead sponsor
-
Other sponsor
The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.
Who can take part
This study's own entry requirements. Only the study team can say for certain whether you qualify.
Who is studied
The study population will consist of approximately 200 patients with diabetic foot ulcers admitted to 5 Azar Hospital, Gorgan, during 2024. Patients will be identified retrospectively from hospital medical records. Both demographic and clinical data, as well as laboratory findings, will be extracted for analysis
- Ages
-
Children (under 18), adults (18 to 64) and older adults (65 and over)
- Sex
-
Anyone
Show the full entry requirements Hide the full entry requirements
Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.
Inclusion Criteria: * Patients admitted to 5 Azar Hospital, Gorgan, in 2024 * Diagnosis of diabetic foot ulcer (DFU) confirmed by medical records * Complete demographic, clinical, and laboratory data available in medical files Exclusion Criteria: * Incomplete or missing medical records * Patients with foot ulcers of non-diabetic etiology * Patients whose key laboratory data are unavailable
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for Diabetes complications are added.
Genom att skicka in godkänner du våra Användarvillkor
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
How to take part
Only the study team decides who joins. These are the ways to reach them.
-
The places running it
1 site. The list below names each one and where it is.
-
The official record
ClinicalTrials.gov lists the study team's own contact details, including names and phone numbers. We don't republish those.
-
A doctor treating you
A doctor who knows your case can contact a study site on your behalf, and can tell you whether this study is worth pursuing at all.
Contacts and locations
Locations
-
5Th Azar Medical Center
RECRUITINGGorgan, Outside of the US, 4917956808, Iran
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Gene therapy shots aim to save legs from amputation in diabetes
- New wound dressing put to the test against diabetic foot ulcers
- Silver and sound: can ultrasound push nanoparticles into diabetic wounds?
- Zapping a leg nerve: can a wearable device help stubborn ulcers heal?
- Wound dressings that trap microbes: scientists test a Drug-Free approach
- Can a traditional herbal mix save limbs from diabetic ulcers?